NASDAQ · Key Statistics

Iterum Therapeutics plc (ITRM) Key Statistics

$0.03 NASDAQ: ITRM Market Cap $1.60M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Iterum Therapeutics plc (ITRM), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-0.06
P/B ratioShare price divided by book value per share.	-0.19
P/S ratioMarket value divided by annual revenue.	4.10
PEG ratioP/E divided by the earnings growth rate.	0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-1.38
EV / RevenueEnterprise value against annual revenue.	62.39
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-1666.67%
Free cash flow yieldFree cash flow as a percentage of market value.	-980.34%
Price / free cash flowMarket value divided by free cash flow.	-0.10

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	-171.28%
Operating marginRevenue left after operating costs.	0.00%
Net marginRevenue left after every cost, including tax and interest.	0.00%
Return on equityProfit as a percentage of shareholders’ equity.	442.32%
Return on assetsProfit as a percentage of total assets.	-62.70%
Return on capital employedOperating profit against the capital the business uses.	-63.75%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	2.13
Quick ratioThe same, excluding inventory.	1.96
Cash ratioCash alone against current liabilities.	1.33
Debt to equityTotal borrowings against shareholders’ equity.	-4.57
Debt to assetsTotal borrowings against total assets.	1.02
Interest coverageHow many times operating profit covers the interest bill.	-11.67

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-1.26
Book value per shareShareholders’ equity divided by shares outstanding.	$-0.16
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$1.60M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$23.60M

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Iterum Therapeutics plc (ITRM) statistics — frequently asked questions

What is Iterum Therapeutics plc's P/E ratio?

Iterum Therapeutics plc (ITRM) trades on a price-to-earnings ratio of -0.06. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Iterum Therapeutics plc's return on equity?

Iterum Therapeutics plc (ITRM) reports a return on equity of 442.32%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Iterum Therapeutics plc carry?

Iterum Therapeutics plc (ITRM) has a debt-to-equity ratio of -4.57, which compares total borrowings with shareholders' equity.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.